8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): May 31, 2006

Commission File No. 0-11178

UTAH MEDICAL PRODUCTS, INC.

(Exact name of Registrant as specified in its charter)

UTAH	87-0342734
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

7043 South 300 West

Midvale, Utah 84047

Address of principal executive offices

Registrant's telephone number: (801) 566-1200

ITEM 1.01 - ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

Effective May 31, 2006, Utah Medical Products, Inc. modified its unsecured line-of-credit with U.S. Bank to extend the maturity date of the note by two years to May 31, 2008. All other terms of the note remain the same.

SIGNATURES

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	UTAH MEDICAL PRODUCTS, INC.
	REGISTRANT
Date:      6/2/2006	By:	/s/ Kevin L. Cornwell
		Kevin L. Cornwell
		CEO

 EXHIBIT INDEX

Index Number	Description
10.1	Fourth Amendment to Loan Agreement, dated May 31, 2006 between Utah Medical Products, Inc. and U.S. Bank National Association

EX-10.1

FOURTH AMENDMENT TO LOAN AGREEMENT

THIS FOURTH AMENDMENT TO LOAN AGREEMENT (the "Amendment") is entered into as of May 31, 2006 by and between UTAH MEDICAL PRODUCTS, a Utah corporation ("Borrower"), and U. S. BANK NATIONAL ASSOCIATION ("Bank").

Recitals

A. Borrower and Bank have entered into that certain Loan Agreement (the “Agreement”) dated as of July 3, 2002 and related documents (as amended by a First Amendment thereto, a Second Amendment thereto, and a Third Amendment thereto) pursuant to which Bank has agreed to extend certain credit to Borrower in accordance with its terms. Capitalized terms shall have the meanings given by the Agreement unless otherwise defined.

B. Borrower and Bank wish to extend the Loan termination date under the Agreement and the maturity date under the Note to May 31, 2008.

Agreement

NOW, THEREFORE, in consideration of the promises contained herein, and each intending to be legally bound hereby, the parties agree as follows:

1. The Agreement and the other Loan Documents are hereby amended to provide that the Loan termination date (and the maturity date under the Note) shall be extended to May 31, 2008.

2. Borrower hereby acknowledges the continued validity and enforceability of the Loan Documents, as amended hereby, and acknowledges that Borrower has no defense, claim or counterclaim with respect to its Obligations under the Loan Documents.

3. All other terms of the Agreement and the other Loan Documents shall remain valid and enforceable as modified hereby.

4. This Amendment may be executed in counterparts.

IN WITNESS WHEREOF, the parties hereto have duly executed this Amendment as of the day and year first above written.

UTAH MEDICAL PRODUCTS	U. S. BANK NATIONAL ASSOCIATION
By:  /s/ Kevin L. Cornwell	By: /s/ David P. Williams
Its:  CEO	Its:  Vice President